Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group

Detalhes bibliográficos
Autor(a) principal: Robert, P.
Data de Publicação: 2018
Outros Autores: Lanctôt, K. L., Agüera-Ortiz, L., Aalten, P., Bremond, F., Defrancesco, M., Hanon, C., David, R., Dubois, B., Dujardin, K., Husain, M., König, A., Levy, R., Mantua, V., Meulien, D., Miller, D., Moebius, H. J., Rasmussen, J., Robert, G., Ruthirakuhan, M., Stella, F. [UNESP], Yesavage, J., Zeghari, R., Manera, V.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.eurpsy.2018.07.008
http://hdl.handle.net/11449/176719
Resumo: Background: Apathy is a very common behavioural and psychological symptom across brain disorders. In the last decade, there have been considerable advances in research on apathy and motivation. It is thus important to revise the apathy diagnostic criteria published in 2009. The main objectives were to: a) revise the definition of apathy; b) update the list of apathy dimensions; c) operationalise the diagnostic criteria; and d) suggest appropriate assessment tools including new technologies. Methods: The expert panel (N = 23) included researchers and health care professionals working on brain disorders and apathy, a representative of a regulatory body, and a representative of the pharmaceutical industry. The revised diagnostic criteria for apathy were developed in a two-step process. First, following the standard Delphi methodology, the experts were asked to answer questions via web-survey in two rounds. Second, all the collected information was discussed on the occasion of the 26th European Congress of Psychiatry held in Nice (France). Results: Apathy was defined as a quantitative reduction of goal-directed activity in comparison to the patient's previous level of functioning (criterion A). Symptoms must persist for at least four weeks, and affect at least two of the three apathy dimensions (behaviour/cognition; emotion; social interaction; criterion B). Apathy should cause identifiable functional impairments (criterion C), and should not be fully explained by other factors, such as effects of a substance or major changes in the patient's environment (Criterion D). Conclusions: The new diagnostic criteria for apathy provide a clinical and scientific framework to increase the validity of apathy as a clinical construct. This should also help to pave the path for apathy in brain disorders to be an interventional target.
id UNSP_345a4c7b5a76a4ac7772205a963fea6b
oai_identifier_str oai:repositorio.unesp.br:11449/176719
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus groupApathyBehaviourBrain disordersEmotionMotivationNeuropsychiatrySocial interactionTreatmentBackground: Apathy is a very common behavioural and psychological symptom across brain disorders. In the last decade, there have been considerable advances in research on apathy and motivation. It is thus important to revise the apathy diagnostic criteria published in 2009. The main objectives were to: a) revise the definition of apathy; b) update the list of apathy dimensions; c) operationalise the diagnostic criteria; and d) suggest appropriate assessment tools including new technologies. Methods: The expert panel (N = 23) included researchers and health care professionals working on brain disorders and apathy, a representative of a regulatory body, and a representative of the pharmaceutical industry. The revised diagnostic criteria for apathy were developed in a two-step process. First, following the standard Delphi methodology, the experts were asked to answer questions via web-survey in two rounds. Second, all the collected information was discussed on the occasion of the 26th European Congress of Psychiatry held in Nice (France). Results: Apathy was defined as a quantitative reduction of goal-directed activity in comparison to the patient's previous level of functioning (criterion A). Symptoms must persist for at least four weeks, and affect at least two of the three apathy dimensions (behaviour/cognition; emotion; social interaction; criterion B). Apathy should cause identifiable functional impairments (criterion C), and should not be fully explained by other factors, such as effects of a substance or major changes in the patient's environment (Criterion D). Conclusions: The new diagnostic criteria for apathy provide a clinical and scientific framework to increase the validity of apathy as a clinical construct. This should also help to pave the path for apathy in brain disorders to be an interventional target.CoBTeK IA Memory Centre University Cote d'AzurSunnybrook Research Institute and Departments of Pharmacology/Toxicology and Psychiatry University of TorontoDepartment of Psychiatry Instituto de Investigación Sanitaria (imas12) Hospital Universitario 12 de Octubre & Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)School for Mental Health and Neuroscience Alzheimer Center LimburgSTARS team - INRIA Sophia AntipolisDepartment of Psychiatry and Psychotherapy Innsbruck Medical UniversityRegional Resource Centre of Old Age Psychiatry Paris Descartes University, Assistance Publique-Hôpitaux de Paris, Corentin-Celton HospitalMemory Center CMRR CHU – CoBTeK lab University Cote d'AzurCentre des Maladies Cognitives et Comportementales (IM2A) Institut du Cerveau et de la Moelle épinière (ICM) UMR-S975 AP-HP Salpêtrière Hospital Sorbonne UniversityNeurology and Movement Disorders Lille University Medical Center Inserm U1171Nuffield Department of Clinical Neurosciences (John Radcliffe Hospital Oxford OX3 9DU) & Department of Experimental Psychology University of OxfordAP-HP Neurology deparment Salpetriere hospital Inserm U 1127 CNRS UMR 7225 Sorbonne Universités UPMC Univ Paris 06 UMR S 1127 Institut du Cerveau et de la Moelle épinière ICM FRONTlab School of medicine Sorbonne UniversitésAgenzia Italiana del Farmaco, via del Tritone 181Clinical Research Neurology Lundbeck SASBracket, Waynemoebius-consult GmbHpsi-napseEA4712 “Comportement et noyaux gris centraux” Université de Rennes 1Laboratorio de Neurociencias LIM27 Departamento e Instituto de Psiquiatria Hospital das Clinicas HCFMUSP Faculdade de Medicina Universidade de Sao Paulo UNESP - Univ Estadual Paulista Biosciences Institute, Campus of Rio ClaroDepartment of Psychiatry and Behavioral Sciences Stanford University School of Medicine Stanford UniversityLaboratorio de Neurociencias LIM27 Departamento e Instituto de Psiquiatria Hospital das Clinicas HCFMUSP Faculdade de Medicina Universidade de Sao Paulo UNESP - Univ Estadual Paulista Biosciences Institute, Campus of Rio ClaroUniversity Cote d'AzurUniversity of TorontoHospital Universitario 12 de Octubre & Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)Alzheimer Center LimburgSTARS team - INRIA Sophia AntipolisInnsbruck Medical UniversityParis Descartes UniversitySorbonne UniversityInserm U1171University of OxfordSorbonne UniversitésAgenzia Italiana del FarmacoClinical Research Neurology Lundbeck SASBracketmoebius-consult GmbHpsi-napseUniversité de Rennes 1Universidade Estadual Paulista (Unesp)Stanford UniversityRobert, P.Lanctôt, K. L.Agüera-Ortiz, L.Aalten, P.Bremond, F.Defrancesco, M.Hanon, C.David, R.Dubois, B.Dujardin, K.Husain, M.König, A.Levy, R.Mantua, V.Meulien, D.Miller, D.Moebius, H. J.Rasmussen, J.Robert, G.Ruthirakuhan, M.Stella, F. [UNESP]Yesavage, J.Zeghari, R.Manera, V.2018-12-11T17:22:11Z2018-12-11T17:22:11Z2018-10-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article71-76application/pdfhttp://dx.doi.org/10.1016/j.eurpsy.2018.07.008European Psychiatry, v. 54, p. 71-76.1778-35850924-9338http://hdl.handle.net/11449/17671910.1016/j.eurpsy.2018.07.0082-s2.0-850516553092-s2.0-85051655309.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Psychiatry1,819info:eu-repo/semantics/openAccess2024-08-16T15:45:29Zoai:repositorio.unesp.br:11449/176719Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-16T15:45:29Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
title Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
spellingShingle Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
Robert, P.
Apathy
Behaviour
Brain disorders
Emotion
Motivation
Neuropsychiatry
Social interaction
Treatment
title_short Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
title_full Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
title_fullStr Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
title_full_unstemmed Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
title_sort Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group
author Robert, P.
author_facet Robert, P.
Lanctôt, K. L.
Agüera-Ortiz, L.
Aalten, P.
Bremond, F.
Defrancesco, M.
Hanon, C.
David, R.
Dubois, B.
Dujardin, K.
Husain, M.
König, A.
Levy, R.
Mantua, V.
Meulien, D.
Miller, D.
Moebius, H. J.
Rasmussen, J.
Robert, G.
Ruthirakuhan, M.
Stella, F. [UNESP]
Yesavage, J.
Zeghari, R.
Manera, V.
author_role author
author2 Lanctôt, K. L.
Agüera-Ortiz, L.
Aalten, P.
Bremond, F.
Defrancesco, M.
Hanon, C.
David, R.
Dubois, B.
Dujardin, K.
Husain, M.
König, A.
Levy, R.
Mantua, V.
Meulien, D.
Miller, D.
Moebius, H. J.
Rasmussen, J.
Robert, G.
Ruthirakuhan, M.
Stella, F. [UNESP]
Yesavage, J.
Zeghari, R.
Manera, V.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv University Cote d'Azur
University of Toronto
Hospital Universitario 12 de Octubre & Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
Alzheimer Center Limburg
STARS team - INRIA Sophia Antipolis
Innsbruck Medical University
Paris Descartes University
Sorbonne University
Inserm U1171
University of Oxford
Sorbonne Universités
Agenzia Italiana del Farmaco
Clinical Research Neurology Lundbeck SAS
Bracket
moebius-consult GmbH
psi-napse
Université de Rennes 1
Universidade Estadual Paulista (Unesp)
Stanford University
dc.contributor.author.fl_str_mv Robert, P.
Lanctôt, K. L.
Agüera-Ortiz, L.
Aalten, P.
Bremond, F.
Defrancesco, M.
Hanon, C.
David, R.
Dubois, B.
Dujardin, K.
Husain, M.
König, A.
Levy, R.
Mantua, V.
Meulien, D.
Miller, D.
Moebius, H. J.
Rasmussen, J.
Robert, G.
Ruthirakuhan, M.
Stella, F. [UNESP]
Yesavage, J.
Zeghari, R.
Manera, V.
dc.subject.por.fl_str_mv Apathy
Behaviour
Brain disorders
Emotion
Motivation
Neuropsychiatry
Social interaction
Treatment
topic Apathy
Behaviour
Brain disorders
Emotion
Motivation
Neuropsychiatry
Social interaction
Treatment
description Background: Apathy is a very common behavioural and psychological symptom across brain disorders. In the last decade, there have been considerable advances in research on apathy and motivation. It is thus important to revise the apathy diagnostic criteria published in 2009. The main objectives were to: a) revise the definition of apathy; b) update the list of apathy dimensions; c) operationalise the diagnostic criteria; and d) suggest appropriate assessment tools including new technologies. Methods: The expert panel (N = 23) included researchers and health care professionals working on brain disorders and apathy, a representative of a regulatory body, and a representative of the pharmaceutical industry. The revised diagnostic criteria for apathy were developed in a two-step process. First, following the standard Delphi methodology, the experts were asked to answer questions via web-survey in two rounds. Second, all the collected information was discussed on the occasion of the 26th European Congress of Psychiatry held in Nice (France). Results: Apathy was defined as a quantitative reduction of goal-directed activity in comparison to the patient's previous level of functioning (criterion A). Symptoms must persist for at least four weeks, and affect at least two of the three apathy dimensions (behaviour/cognition; emotion; social interaction; criterion B). Apathy should cause identifiable functional impairments (criterion C), and should not be fully explained by other factors, such as effects of a substance or major changes in the patient's environment (Criterion D). Conclusions: The new diagnostic criteria for apathy provide a clinical and scientific framework to increase the validity of apathy as a clinical construct. This should also help to pave the path for apathy in brain disorders to be an interventional target.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-11T17:22:11Z
2018-12-11T17:22:11Z
2018-10-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.eurpsy.2018.07.008
European Psychiatry, v. 54, p. 71-76.
1778-3585
0924-9338
http://hdl.handle.net/11449/176719
10.1016/j.eurpsy.2018.07.008
2-s2.0-85051655309
2-s2.0-85051655309.pdf
url http://dx.doi.org/10.1016/j.eurpsy.2018.07.008
http://hdl.handle.net/11449/176719
identifier_str_mv European Psychiatry, v. 54, p. 71-76.
1778-3585
0924-9338
10.1016/j.eurpsy.2018.07.008
2-s2.0-85051655309
2-s2.0-85051655309.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv European Psychiatry
1,819
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 71-76
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128121414615040